Stage IV lung cancer
Clinical trials for Stage IV lung cancer explained in plain language.
Never miss a new study
Get alerted when new Stage IV lung cancer trials appear
Sign up with your email to follow new studies for Stage IV lung cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radiation plus immunotherapy: a new hope for hard-to-treat lung cancer?
Disease control OngoingThis study is for people with advanced non-small cell lung cancer that does not have the PD-L1 marker, making it harder to treat with immunotherapy alone. The trial compares standard immunotherapy (with or without chemotherapy) to the same treatment plus radiation therapy. The go…
Matched conditions: STAGE IV LUNG CANCER
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New online program aims to ease burden on lung cancer caregivers
Symptom relief OngoingThis study tests a new web-based tool called CONNECT, designed to help caregivers of people with stage II to IV lung cancer find support resources. About 216 caregivers will use the tool and have sessions with a navigator to see if it helps them feel more supported. The goal is t…
Matched conditions: STAGE IV LUNG CANCER
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Spiritual support may ease anxiety in advanced cancer patients
Symptom relief OngoingThis study tests whether spiritual care sessions can improve spiritual wellbeing, reduce anxiety and depression, and increase satisfaction with care for people with stage IV lung or gastrointestinal cancer. About 36 adults will be randomly assigned to receive either spiritual car…
Matched conditions: STAGE IV LUNG CANCER
Sponsor: Indiana University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Shorter radiation may ease lung cancer treatment burden
Symptom relief OngoingThis study tested a shorter course of high-dose radiation for people with stage IV lung cancer. The goal was to see if giving fewer, larger doses over fewer days could be as safe and effective as the standard longer schedule. 37 participants received radiation every other day for…
Matched conditions: STAGE IV LUNG CANCER
Sponsor: University Hospitals Coventry and Warwickshire NHS Trust • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Real-World study tracks osimertinib combo for lung cancer
Knowledge-focused OngoingThis study is watching how patients with EGFR-mutated non-small cell lung cancer do when they receive standard treatment with osimertinib (Tagrisso) alone or with chemotherapy in routine medical practice. About 538 people with advanced lung cancer will be followed to see how long…
Matched conditions: STAGE IV LUNG CANCER
Sponsor: PrECOG, LLC. • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC